ENTITY
Gracell Biotechnologies Inc

Gracell Biotechnologies Inc (GRCL US)

13
Analysis
Health CareUnited States
Gracell Biotechnologies Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on discovering and developing cell therapies to address medical needs in the treatment of cancer. Gracell Biotechnologies aims to disrupt conventional approaches to CAR-T cell therapies with technology platforms-FasTCAR and TruUCAR.
more
Refresh
Company Presentation13 Dec 2023 20:00
Company Presentation01 Nov 2023 20:00
Company Presentation14 Jun 2021 20:00
Company Presentation17 Aug 2021 20:00
Company Presentation14 Mar 2022 20:00
x